Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients

Long-term survivors of glioblastoma: clinical features and molecular analysis

(2009) Yukihiko Sonoda et al.   ACTA NEUROCHIRURGICA

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

(2009) J Dunn et al.   BRITISH JOURNAL OF CANCER

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation

(2009) Philippe Metellus et al.   CANCER

Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases

(2009) Maurizio Salvati et al.   JOURNAL OF NEURO-ONCOLOGY

No association of (−131C→G) variant of CHI3L1 gene with risk of glioblastoma and prognosis

(2009) Blandine Boisselier et al.   JOURNAL OF NEURO-ONCOLOGY

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

(2009) Lucie Karayan-Tapon et al.   JOURNAL OF NEURO-ONCOLOGY

THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS

(2009) Van Thang Cao et al.   NEUROSURGERY

Selective repression of YKL-40 by NF-κB in glioma cell lines involves recruitment of histone deacetylase-1 and -2

(2008) Krishna P. Bhat et al.   FEBS LETTERS